Does anti-tumour necrosis factor alpha treatment modify the tuberculin PPD response?
Joven
B E
BE
Almodóvar
R
R
Galindo
M
M
Mateo
I
I
Pablos
J L
JL
D000328:Adult; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D001168:Arthritis / Q000188:drug therapy*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000517:prevention & control; D007111:Immunity, Cellular / Q000187:drug effects; D000069285:Infliximab; D008875:Middle Aged; D009894:Opportunistic Infections / Q000517:prevention & control; D011446:Prospective Studies; D014374:Tuberculin Test; D014376:Tuberculosis / Q000517:prevention & control; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab